Andrew Oakley
Fortune : 199 015 $ au 30/06/2026
Fortune : 199 015 $ au 30/06/2026
Andrew J.
Oakley is currently Director at Virometix AG, Executive Director at Novaremed AG, Director at Brian Oakley Ltd. since 2003, Director at Oakley Coachbuilders Ltd. since 2014, Director at UNION Therapeutics A, Director at Metys Pharmaceuticals AG, Independent Director at Tribeca Strategic Acquisition Corp.
starting 2026, and Member of The Institute of Chartered Accountants in Australia since 1987.
Former roles include Non-Executive Chairman at Onconetix, Inc. from 2025 to 2026, CFO, Secretary & Executive Director at Vectura Group Ltd. from 2015 to 2016, Chief Financial Officer, Secretary & Director at Vectura GmbH, Chief Financial Officer & Executive Vice President at Actelion Ltd., Chief Financial Officer & Executive Vice President at Nxera Pharma Co., Ltd. from 2017 to 2018, Chief Financial Officer at NovImmune SA in 2014, Member-Supervisory Board at Ventaleon GmbH, Chief Financial Officer & Executive Vice President at Actelion Pharmaceuticals Ltd. from 2003 to 2013, and Chief Financial Officer & Executive Vice President at Autolus Therapeutics Plc from 2018 to 2023.
Education includes undergraduate studies at Macquarie University and an MBA from London Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,43 % | 28/05/2026 | 20 000 ( 0,43 % ) | 199 000 $ | 30/06/2026 |
| 13/03/2026 | 13 ( 0 % ) | 15 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
The Institute of Chartered Accountants in Australia | Corporate Officer/Principal | 21/05/2010 |
UNION Therapeutics A/S
UNION Therapeutics A/S Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Directeur/Membre du Conseil | - |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Develops safer and more efficacious drugs for chronic and life-threatening diseases | Directeur/Membre du Conseil | - |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | - |
Brian Oakley Ltd.
Brian Oakley Ltd. Real Estate DevelopmentFinance Leases and operates real estate properties | Directeur/Membre du Conseil | 01/04/2003 |
Oakley Coachbuilders Ltd.
Oakley Coachbuilders Ltd. Personnel ServicesCommercial Services Provides human resources provision and management services | Directeur/Membre du Conseil | 23/06/2014 |
Virometix AG
Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ONCONETIX, INC. | Président | 20/04/2026 |
| AUTOLUS THERAPEUTICS PLC | Directeur Financier/CFO | 01/01/2023 |
| ░░░░░ ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 18 |
|---|---|
Vectura Group Ltd.
Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
Macquarie University
Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nxera Pharma Co., Ltd.
Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
Novimmune SA
Novimmune SA BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
The Institute of Chartered Accountants in Australia | |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Develops safer and more efficacious drugs for chronic and life-threatening diseases | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes molecular weight drugs | Health Technology |
Virometix AG
Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
UNION Therapeutics A/S
UNION Therapeutics A/S Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Health Technology |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Brian Oakley Ltd.
Brian Oakley Ltd. Real Estate DevelopmentFinance Leases and operates real estate properties | Finance |
Oakley Coachbuilders Ltd.
Oakley Coachbuilders Ltd. Personnel ServicesCommercial Services Provides human resources provision and management services | Commercial Services |
Onconetix, Inc.
Onconetix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs and diagnostic test for cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national